Request for Proposals - Supply of abiraterone and novel androgen receptor inhibitors (nARIs)

Pharmac invites proposals for the supply of abiraterone and novel androgen receptor inhibitors in New Zealand. This request for proposals (RFP) letter incorporates the following schedules and attachments: · Schedule 1 specifies the pharmaceuticals for which Pharmac is requesting proposals and sets out the background to the RFP and the types of proposals sought; · Schedule 2 describes the process that Pharmac expects to follow in relation to the RFP; · Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceuticals; · Attachment 1 is the form in which you can provide non-price information; · Attachment 2 is the form in which you can provide price information; · Attachment 3 contains Pharmac’s standard terms and conditions for supply of pharmaceuticals; · Attachment 4 contains the standard Principal Supply Status terms; and · Attachment 5 is the New Zealand Government Supplier Code of Conduct. If you wish to submit a proposal, you must submit it to Pharmac via the Government Electronic Tenders Service (GETS) no later than 12:00pm (New Zealand time) on 13 August 2026. If you have any enquiries about this RFP, you should submit them via GETS, using the questions and answers function before 12:00pm (New Zealand time) on 31 July 2026. Responses to all enquires will be published on GETS. If you do need to get in touch via email, please contact [email protected] We will also be holding an online supplier briefing 1:00pm (New Zealand time) on 16 July 2026. If you are interested in attending this, please register your interest by emailing [email protected] We look forward to receiving your proposal.